---
schema_version: "secwatch.filing_event.v1"
accession: "0001640334-23-002017"
form_type: "8-K"
ticker: "LEXX"
cik: "0001348362"
company_name: "Lexaria Bioscience Corp."
filed_at: "2023-11-03T23:59:59+00:00"
generated_at: "2026-06-08T22:10:33.288703+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.5
calibrated_materiality_score: 0.5
confidence: "high"
source: SEC EDGAR
---

# Lexaria Bioscience regains Nasdaq bid price compliance; warrant exercises yield $444,895

## Summary
- Received Nasdaq letter on Nov 3, 2023 confirming cure of $1.00 minimum bid price deficiency after 11 consecutive days above $1.00 (Oct 19 - Nov 2).
- Since Oct 24, 2023, exercised warrants for 468,279 shares at $0.95/share, generating gross proceeds of $444,865.
- Pre-funded warrants exercised for 303,058 shares at $0.0001/share, generating gross proceeds of $30.31.
- Total common shares outstanding after these exercises: 9,752,259.

## SEC filing metadata
- accession: 0001640334-23-002017
- form_type: 8-K
- ticker: LEXX
- cik: 0001348362
- company_name: Lexaria Bioscience Corp.
- filed_at: 2023-11-03T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.5
- calibrated_materiality_score: 0.5
- confidence: high
- sec_items: 8.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1348362/000164033423002017/0001640334-23-002017-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1348362/000164033423002017/lxrp_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001640334-23-002017
- JSON: https://secwatch.observer/filing/0001640334-23-002017.json
- Plain text: https://secwatch.observer/filing/0001640334-23-002017.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.